ZW1790A1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number: ZW1790A1
Authority: ZW; Zimbabwe
Prior art keywords: pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 1989-02-23

Application number

ZW17/90A

Other languages

English (en)

Inventor

Kumar Chopra Sham

Tarum Makadia Tribhovan

Original Assignee

Glaxo Canada

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-02-23

Filing date

1990-02-21

Publication date

1991-10-16

1990-02-21 Application filed by Glaxo Canada filed Critical Glaxo Canada

1991-10-16 Publication of ZW1790A1 publication Critical patent/ZW1790A1/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

ZW17/90A 1989-02-23 1990-02-21 Pharmaceutical compositions ZW1790A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB898904182A GB8904182D0 (en)	1989-02-23	1989-02-23	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
ZW1790A1 true ZW1790A1 (en)	1991-10-16

Family

ID=10652220

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZW17/90A ZW1790A1 (en)	1989-02-23	1990-02-21	Pharmaceutical compositions

Country Status (26)

Country	Link
US (1)	US5028432A (da)
JP (1)	JP2856817B2 (da)
KR (1)	KR940006271B1 (da)
AT (1)	AT401727B (da)
AU (1)	AU629303B2 (da)
BE (1)	BE1003123A3 (da)
CA (1)	CA2010692C (da)
CH (1)	CH680567A5 (da)
CY (1)	CY1734A (da)
DE (1)	DE4005650C2 (da)
DK (1)	DK170209B1 (da)
FR (1)	FR2643263B1 (da)
GB (2)	GB8904182D0 (da)
HK (1)	HK89493A (da)
HU (1)	HU211930A9 (da)
IE (1)	IE63179B1 (da)
IL (1)	IL93490A (da)
IT (1)	IT1240768B (da)
LU (1)	LU87681A1 (da)
NL (1)	NL193267C (da)
NZ (1)	NZ232642A (da)
PH (1)	PH26972A (da)
SA (1)	SA90100287B1 (da)
SE (1)	SE512412C2 (da)
ZA (1)	ZA901348B (da)
ZW (1)	ZW1790A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992004893A1 (en) *	1990-09-13	1992-04-02	Smithkline Beecham Corporation	Non-aqueous liquid oral suspensions
US5571533A (en) *	1992-02-07	1996-11-05	Recordati, S.A., Chemical And Pharmaceutical Company	Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
AU669952B2 (en) *	1992-10-16	1996-06-27	Glaxo Group Limited	Taste-masking compositions of ranitidine
US5433951A (en) *	1993-10-13	1995-07-18	Bristol-Myers Squibb Company	Sustained release formulation containing captopril and method
DE4341310A1 (de) *	1993-12-03	1995-06-08	Hexal Pharma Gmbh	Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
GB9325445D0 (en)	1993-12-13	1994-02-16	Cortecs Ltd	Pharmaceutical formulations
US5407687A (en) *	1994-02-22	1995-04-18	Glaxo Inc.	Ranitidine solid dosage form
GB9405304D0 (en) *	1994-03-16	1994-04-27	Scherer Ltd R P	Delivery systems for hydrophobic drugs
US5538737A (en) *	1994-11-30	1996-07-23	Applied Analytical Industries, Inc.	Oral compositions of H2 -antagonists
GB9705813D0 (en) *	1997-03-20	1997-05-07	Smithkline Beecham Plc	Novel compositions
AR013261A1 (es) *	1997-08-01	2000-12-13	Smithkline Beecham Corp	Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
ATE374602T1 (de) *	2001-12-21	2007-10-15	Supernus Pharmaceuticals Inc	Orale kapselformulierung mit verbesserter physikalischer stabilität
JP2006518380A (ja) *	2003-01-31	2006-08-10	スミスクライン・ビーチャム・コーポレイション	固体分散体組成物
KR101152470B1 (ko)	2003-08-13	2012-06-01	바이오콘 리미티드	치료제용 마이크로-입자 지방산 염 고형 투약 제형
MX2012013955A (es)	2010-06-23	2013-01-24	Colgate Palmolive Co	Composiciones terapeuticas bucales.
US9161891B2 (en)	2010-12-20	2015-10-20	Colgate-Palmolive Company	Gelatin encapsulated oral care composition containing dental occlusion actives, hydrophobic viscosity modifier and oil carrier
CN107088168A (zh)	2010-12-20	2017-08-25	高露洁-棕榄公司	包含牙齿封闭活性物的非水性口腔护理组合物
CN103260466B (zh)	2010-12-20	2016-08-17	高露洁-棕榄公司	含有亲水性活性物质、疏水性结构化剂和油载体的明胶包囊的口腔护理组合物
US20200038376A1 (en) *	2016-11-01	2020-02-06	Johnson & Johnson Consumer Inc.	Liquid oral pharmaceutical dosage form comprising an histamine h2-receptor antagonist and an antacid
CN109010303B (zh) *	2017-06-09	2021-05-07	苏州科伦药物研究有限公司	一种盐酸雷尼替丁胶囊的工业制备方法
KR102108153B1 (ko) *	2017-07-05	2020-05-07	(주)동구바이오제약	생체 이용률 및 안정성이 개선된 레티노이드를 함유하는 약제학적 조성물
KR102928295B1 (ko) *	2018-09-07	2026-02-13	알.피.쉐러 테크놀러지즈 엘엘씨	경화 및 낮은 hlb 계면 활성제(들)의 첨가를 통한 고체 또는 반고체 지질 기반 제형 안정화

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3374146A (en) *	1966-04-18	1968-03-19	American Cyanamid Co	Sustained release encapsulation
DE2360796B2 (de) *	1973-12-06	1977-06-02	Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München	Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
GB1565966A (en) *	1976-08-04	1980-04-23	Allen & Hanburys Ltd	Aminoalkyl furan derivatives
IT1090703B (it) *	1976-12-03	1985-06-26	Scherer Ltd R P	Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS5919524B2 (ja) *	1976-12-17	1984-05-07	中外製薬株式会社	安定な１α−ヒドロキシビタミンＤ類含有製剤
GB1572226A (en) *	1977-11-03	1980-07-30	Hoechst Uk Ltd	Pharmaceutical preparations in solid unit dosage form
JPS55136219A (en) *	1979-04-11	1980-10-23	Sumitomo Chem Co Ltd	Diazepam oily drug
EP0040489A1 (en) *	1980-05-17	1981-11-25	FISONS plc	Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine
GB2084580B (en) *	1980-10-01	1984-07-04	Glaxo Group Ltd	Aminoalkyl furan derivative
IL63968A (en) *	1980-10-01	1985-10-31	Glaxo Group Ltd	Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
DE3264782D1 (en) *	1981-10-16	1985-08-22	Sanol Arznei Schwarz Gmbh	Medicinal formulation
JPS58174308A (ja) *	1982-04-06	1983-10-13	Fujimoto Seiyaku Kk	レクタルカプセル坐剤
CA1211374A (en) *	1982-05-14	1986-09-16	Eszter Cholnoky	Pharmaceutical compositions containing more active ingredients
DE3237814A1 (de) *	1982-10-12	1984-04-12	Warner-Lambert Co., 07950 Morris Plains, N.J.	Wasserfreie emulsionen und verwendung derselben
EP0152432B1 (en) *	1983-08-01	1989-03-01	R.P. Scherer Corporation	Sustained release method and product
GB8903804D0 (en) *	1989-02-20	1989-04-05	Sandoz Ltd	Improvements in or relating to organic compounds
GB8426738D0 (en) *	1984-10-23	1984-11-28	Scras	Pyridine derivatives
GB8516083D0 (en) *	1985-06-25	1985-07-31	Glaxo Group Ltd	Heterocyclic compounds
JPH07549B2 (ja) *	1986-07-03	1995-01-11	ゼリア新薬工業株式会社	軟カプセル充填用組成物
DE3629386A1 (de) *	1986-08-29	1988-03-03	Scherer Gmbh R P	Gelatinekapseln und verfahren zu ihrer herstellung
IL90245A (en) *	1988-05-11	1994-04-12	Glaxo Group Ltd	Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
JPH0482832A (ja) *	1988-09-20	1992-03-16	Glaxo Group Ltd	医薬組成物

1989
- 1989-02-23 GB GB898904182A patent/GB8904182D0/en active Pending
1990
- 1990-02-21 ZW ZW17/90A patent/ZW1790A1/xx unknown
- 1990-02-21 LU LU87681A patent/LU87681A1/fr unknown
- 1990-02-22 AT AT0042190A patent/AT401727B/de not_active IP Right Cessation
- 1990-02-22 DE DE4005650A patent/DE4005650C2/de not_active Expired - Lifetime
- 1990-02-22 IE IE65190A patent/IE63179B1/en not_active IP Right Cessation
- 1990-02-22 FR FR909002187A patent/FR2643263B1/fr not_active Expired - Lifetime
- 1990-02-22 PH PH40086A patent/PH26972A/en unknown
- 1990-02-22 US US07/482,903 patent/US5028432A/en not_active Expired - Lifetime
- 1990-02-22 AU AU50073/90A patent/AU629303B2/en not_active Expired
- 1990-02-22 NL NL9000428A patent/NL193267C/nl not_active IP Right Cessation
- 1990-02-22 GB GB9004016A patent/GB2229094B/en not_active Expired - Lifetime
- 1990-02-22 IL IL9349090A patent/IL93490A/en not_active IP Right Cessation
- 1990-02-22 KR KR1019900002250A patent/KR940006271B1/ko not_active Expired - Lifetime
- 1990-02-22 ZA ZA901348A patent/ZA901348B/xx unknown
- 1990-02-22 JP JP2042288A patent/JP2856817B2/ja not_active Expired - Lifetime
- 1990-02-22 IT IT47659A patent/IT1240768B/it active IP Right Grant
- 1990-02-22 CH CH569/90A patent/CH680567A5/fr not_active IP Right Cessation
- 1990-02-22 NZ NZ232642A patent/NZ232642A/en unknown
- 1990-02-22 SE SE9000625A patent/SE512412C2/sv unknown
- 1990-02-22 BE BE9000197A patent/BE1003123A3/fr not_active IP Right Cessation
- 1990-02-22 DK DK048090A patent/DK170209B1/da not_active IP Right Cessation
- 1990-02-22 CA CA002010692A patent/CA2010692C/en not_active Expired - Lifetime
- 1990-06-23 SA SA90100287A patent/SA90100287B1/ar unknown
1993
- 1993-08-26 HK HK894/93A patent/HK89493A/xx not_active IP Right Cessation
1994
- 1994-05-06 CY CY173494A patent/CY1734A/en unknown
1995
- 1995-06-29 HU HU95P/P00543P patent/HU211930A9/hu unknown

Also Published As

Publication number	Publication date
US5028432A (en)	1991-07-02
BE1003123A3 (fr)	1991-12-03
SA90100287B1 (ar)	1999-08-15
IL93490A (en)	1994-07-31
CA2010692A1 (en)	1990-08-23
JP2856817B2 (ja)	1999-02-10
IT9047659A0 (it)	1990-02-22
IE63179B1 (en)	1995-03-22
HU211930A9 (en)	1996-01-29
FR2643263B1 (fr)	1994-09-16
NL9000428A (nl)	1990-09-17
GB9004016D0 (en)	1990-04-18
IE900651L (en)	1990-08-23
HK89493A (en)	1993-09-03
KR940006271B1 (ko)	1994-07-14
PH26972A (en)	1992-12-28
DK48090A (da)	1990-08-24
DE4005650A1 (de)	1990-09-06
NZ232642A (en)	1992-07-28
SE9000625D0 (sv)	1990-02-22
LU87681A1 (fr)	1991-10-08
CA2010692C (en)	1995-12-12
GB2229094A (en)	1990-09-19
DE4005650C2 (de)	1999-03-25
SE512412C2 (sv)	2000-03-13
GB8904182D0 (en)	1989-04-05
IT1240768B (it)	1993-12-17
ATA42190A (de)	1996-04-15
GB2229094B (en)	1993-01-06
IL93490A0 (en)	1990-11-29
NL193267C (nl)	1999-05-06
IT9047659A1 (it)	1991-08-22
JPH03200728A (ja)	1991-09-02
SE9000625L (sv)	1990-08-24
DK170209B1 (da)	1995-06-19
AU629303B2 (en)	1992-10-01
ZA901348B (en)	1991-03-27
CY1734A (en)	1994-05-06
DK48090D0 (da)	1990-02-22
NL193267B (nl)	1999-01-04
KR900012612A (ko)	1990-09-01
AU5007390A (en)	1990-08-30
CH680567A5 (da)	1992-09-30
FR2643263A1 (fr)	1990-08-24
AT401727B (de)	1996-11-25

Publication	Publication Date	Title
GB9025491D0 (en)	1991-01-09	Pharmaceutical compositions
GB2219940B (en)	1992-01-02	Pharmaceutical compositions
ZA901348B (en)	1991-03-27	Pharmaceutical compositions
GB8909022D0 (en)	1989-06-07	Pharmaceutical compositions
GB8916072D0 (en)	1989-08-31	Pharmaceutical compositions
GB2232891B (en)	1993-02-03	Pharmaceutical composition
HUT56269A (en)	1991-08-28	Pharmaceutical compositions
ZA905512B (en)	1992-03-25	Pharmaceutical compositions
GB8909906D0 (en)	1989-06-14	Pharmaceutical compositions
GB2217202B (en)	1991-10-02	Trimelamol-containing pharmaceutical compositions
IL89935A0 (en)	1989-12-15	Pharmaceutical compositions
GB8922129D0 (en)	1989-11-15	Pharmaceutical compositions
GB8917287D0 (en)	1989-09-13	Pharmaceutical compositions
GB8902564D0 (en)	1989-03-22	Pharmaceutical compositions
GB8914099D0 (en)	1989-08-09	Pharmaceutical compositions
GB8927109D0 (en)	1990-01-31	Pharmaceutical compositions
IE892802L (en)	1990-03-01	Pharmaceutical compositions
GB8919130D0 (en)	1989-10-04	Pharmaceutical compositions
IE894216L (en)	1990-06-30	Pharmaceutical compositions
GB8919447D0 (en)	1989-10-11	Pharmaceutical compositions
GB8915044D0 (en)	1989-08-23	Pharmaceutical compositions
GB8916069D0 (en)	1989-08-31	Pharmaceutical compositions
GB8916070D0 (en)	1989-08-31	Pharmaceutical compositions
IE891521L (en)	1989-11-11	Pharmaceutical compositions
IE892803L (en)	1990-03-01	Pharmaceutical compositions